Phospholipase C-Mediated Hydrolysis of Phosphatidylcholine Is a Target of Transforming Growth Factor βl Inhibitory Signals

References

• Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56:779–827.
   PubMed Web of Science ®Google Scholar
• Berridge, M. J. 1987. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56:159–194.
   PubMed Web of Science ®Google Scholar
• Birchmeier, C., D. Broek, and M. Wigler. 1985. RAS proteins can induce meiosis in Xenopus oocytes. Cell 43:615–621.
   PubMed Web of Science ®Google Scholar
• Bligh, E., and W. Dyer. 1959. A rapid method for total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911–917.
   PubMedGoogle Scholar
• Cantley, L. C., K. R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff. 1991. Oncogenes and signal transduction. Cell 64:281–302.
   PubMed Web of Science ®Google Scholar
• Coffey, R. J., C. C. Bascom, N. J. Sipes, R. Graves-Deal, B. E. Weissman, and H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol. Cell. Biol. 8:3088–3093.
   PubMed Web of Science ®Google Scholar
• Colman, A. 1984. Translation of eukaryotic messenger RNA in Xenopus oocytes, p. 271–302. In B. D. Hames and S. J. Higgins (ed.), Transcription and translation: a practical approach. IRL Press, Washington, D.C.
   Google Scholar
• Cross, M., and T. M. Dexter. 1991. Growth factors in development, transformation, and tumorigenesis. Cell 64:271–280.
   PubMed Web of Science ®Google Scholar
• Diaz-Meco, M. T., P. Larrodera, M. Lopez-Barahona, M. E. Cornet, P. G. Barreno, and J. Moscat. 1989. Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by muscarinic agonists. Biochem. J. 263:115–120.
   PubMedGoogle Scholar
• Doolittle, R. F., M. W. Hunkapiller, L. E. Hood, S. G. Devare, K. C. Kobins, and S. A. Aaronson. 1983. Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221:275–277.
   PubMed Web of Science ®Google Scholar
• Exton, J. H. 1990. Signalling through phosphatidylcholine breakdown. J. Biol. Chem. 265:1–4.
   PubMed Web of Science ®Google Scholar
• García de Herreros, A., I. Dominguez, M. T. Diaz-Meco, G. Graziani, M. E. Cornet, P. H. Guddal, T. Johansen, and J. Moscat. 1991. Requirement of phospholipase C-catalyzed hydrolysis of phosphatidylcholine for maturation of Xenopus laevis oocytes in response to insulin and ras p21. J. Biol. Chem. 266:6825–6829.
   PubMedGoogle Scholar
• Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249–270.
   PubMed Web of Science ®Google Scholar
• Johansen, T., T. Holm, P. H. Guddal, K. Sletten, F. B. Haugli, and C. Little. 1988. Cloning and sequencing of the gene encoding the phosphatidylcholine-preferring phospholipase C of Bacillus cereus. Gene 65:293–304.
   PubMed Web of Science ®Google Scholar
• Korn, L. J., C. W. Siebel, F. McCormick, and R. A. Roth. 1987. Ras p21 as a potential mediator of insulin action in Xenopus oocytes. Science 236:840–842.
   PubMedGoogle Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185.
   PubMed Web of Science ®Google Scholar
• Laiho, M., F. M. B. Weis, F. T. Boyd, R. A. Ignotz, and J. Massague. 1991. Responsiveness to transforming growth fac- tor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J. Biol. Chem. 266:9108–9112.
   PubMed Web of Science ®Google Scholar
• Larrodera, P., M. E. Cornet, M. T. Diaz-Meco, M. Lopez-Barahona, I. Diaz-Laviada, P. H. Guddal, T. Johansen, and J. Moscat. 1990. Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis. Cell 61:1113–1120.
   PubMedGoogle Scholar
• Like, B., and J. Massague. 1986. The antiproliferative effect of type β transforming growth factor occurs at a level distal from receptors for growth-activating factors. J. Biol. Chem. 261:13426–13429.
   PubMedGoogle Scholar
• Little, C. 1988. Phospholipase C. Biochem. Soc. Trans. 17:271–273.
   Google Scholar
• Lopez-Barahona, M., P. L. Kaplan, M. E. Cornet, M. T. Diaz-Meco, P. Larrodera, I. Diaz-Laviada, A. M. Municio, and J. Moscat. 1990. Kinetic evidence of a rapid activation of phosphatidylcholine hydrolysis by Ki-ras oncogene. J. Biol. Chem. 265:9022–9026.
   PubMed Web of Science ®Google Scholar
• Lyons, R. M., and H. L. Moses. 1990. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:467–473.
   PubMedGoogle Scholar
• Moscat, J., T. P. Fleming, C. J. Molloy, M. Lopez-Barahona, and S. A. Aaronson. 1989. The calcium signal for BALB/MK keratinocyte terminal differentiation induces sustained alterations in phosphoinositide metabolism without protein kinase C activation. J. Biol. Chem. 264:11228–11235.
   PubMed Web of Science ®Google Scholar
• Moses, H. L., E. H. Yang, and J. A. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245–247.
   PubMed Web of Science ®Google Scholar
• Murray, A. W., and M. W. Kirschner. 1989. Cyclin synthesis drives the early embryonic cell cycle. Nature (London) 339:275–286.
   PubMed Web of Science ®Google Scholar
• Myrnes, B. J., and C. Little. 1980. A simple purification scheme yielding crystalline phospholipase C from Bacillus cereus. Acta Chem. Scand. Sect. B 32:375–377.
   Google Scholar
• Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittlekow, K. Münger, P. M. Howley, and H. L. Moses. 1990. TGF-βl inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785.
   PubMed Web of Science ®Google Scholar
• Price, B. D., J. D. H. Morris, C. J. Marshall, and A. Hall. 1989. Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation. J. Biol. Chem. 264:16638–16643.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement of c-ras proteins during viral oncogene transformation. Nature (London) 320:540–541.
   PubMed Web of Science ®Google Scholar
• Weissman, B. E., and S. A. Aaronson. 1985. Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce alterations in the terminal differentiation program. Mol. Cell. Biol. 5:3386–3396.
   PubMedGoogle Scholar